Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 579
5
Diseases
34
Unique genes
0.227
Avg. similarity score
Congenital cerebellar ataxia
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital cerebellar ataxia
Chondromyxoid fibroma
Spinocerebellar ataxia, autosomal recessive 13
Temporal lobe epilepsy
Autosomal recessive spinocerebellar ataxia 18
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital cerebellar ataxia | 4 | 4 | 2 |
| Chondromyxoid fibroma | 3 | 3 | 1 |
| Spinocerebellar ataxia, autosomal recessive 13 | 3 | 3 | 1 |
| Temporal lobe epilepsy | 3 | 3 | 33 |
| Autosomal recessive spinocerebellar ataxia 18 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| GRM1 | 4 / 5 | Chondromyxoid fibroma, Congenital cerebellar ataxia, Spinocerebellar ataxia, autosomal recessive 13, Temporal lobe epilepsy |
| GRID2 | 2 / 5 | Autosomal recessive spinocerebellar ataxia 18, Congenital cerebellar ataxia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Neuroactive ligand-receptor interaction | KEGG | 16 / 370 | 15.3× | 6.35e-16 | 2.30e-13 ✓ sig. |
| G alpha (i) signalling events | Reactome | 10 / 249 | 14.2× | 1.04e-9 | 9.62e-8 ✓ sig. |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | Reactome | 5 / 38 | 46.5× | 6.28e-8 | 3.73e-6 ✓ sig. |
| Calcium signaling pathway | KEGG | 8 / 254 | 11.1× | 4.04e-7 | 1.90e-5 ✓ sig. |
| Peptide ligand-binding receptors | Reactome | 6 / 106 | 20.0× | 4.51e-7 | 2.09e-5 ✓ sig. |
| Glutamatergic synapse | KEGG | 6 / 116 | 18.3× | 7.69e-7 | 3.31e-5 ✓ sig. |
| Phospholipase D signaling pathway | KEGG | 5 / 149 | 11.9× | 5.72e-5 | 1.21e-3 ✓ sig. |
| Cation-coupled Chloride cotransporters | Reactome | 2 / 7 | 101× | 1.62e-4 | 2.78e-3 ✓ sig. |
| VEGF binds to VEGFR leading to receptor dimerization | Reactome | 2 / 8 | 88.3× | 2.16e-4 | 3.48e-3 ✓ sig. |
| Platelet homeostasis | Reactome | 2 / 8 | 88.3× | 2.16e-4 | 3.48e-3 ✓ sig. |
| Cocaine addiction | KEGG | 3 / 49 | 21.6× | 3.49e-4 | 5.06e-3 ✓ sig. |
| Elevation of cytosolic Ca2+ levels | Reactome | 2 / 13 | 54.3× | 5.95e-4 | 7.64e-3 ✓ sig. |
| VEGFR2 mediated cell proliferation | Reactome | 2 / 14 | 50.5× | 6.93e-4 | 8.58e-3 ✓ sig. |
| G alpha (q) signalling events | Reactome | 4 / 172 | 8.2× | 1.35e-3 | 1.42e-2 ✓ sig. |
| Purinergic signaling in leishmaniasis infection | Reactome | 2 / 24 | 29.4× | 2.06e-3 | 1.95e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | GO:0007196 | 5 / 9 | 305× | 1.84e-12 | 8.35e-10 ✓ sig. |
| chemical synaptic transmission | GO:0007268 | 10 / 236 | 23.3× | 8.58e-12 | 3.32e-9 ✓ sig. |
| G protein-coupled glutamate receptor signaling pathway | GO:0007216 | 5 / 14 | 196× | 2.90e-11 | 9.98e-9 ✓ sig. |
| synaptic signaling via neuropeptide | GO:0099538 | 4 / 9 | 244× | 1.14e-9 | 2.60e-7 ✓ sig. |
| regulation of synaptic transmission, glutamatergic | GO:0051966 | 5 / 33 | 83.3× | 3.36e-9 | 6.74e-7 ✓ sig. |
| positive regulation of MAPK cascade | GO:0043410 | 7 / 224 | 17.2× | 1.32e-7 | 1.61e-5 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 10 / 667 | 8.2× | 1.89e-7 | 2.16e-5 ✓ sig. |
| locomotory behavior | GO:0007626 | 5 / 99 | 27.8× | 9.28e-7 | 8.10e-5 ✓ sig. |
| sensory perception of pain | GO:0019233 | 4 / 44 | 50.0× | 1.18e-6 | 9.82e-5 ✓ sig. |
| positive regulation of endothelial cell chemotaxis | GO:2001028 | 3 / 13 | 127× | 1.55e-6 | 1.24e-4 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 6 / 217 | 15.2× | 2.35e-6 | 1.73e-4 ✓ sig. |
| cellular response to ATP | GO:0071318 | 3 / 19 | 86.8× | 5.23e-6 | 3.28e-4 ✓ sig. |
| glutamate receptor signaling pathway | GO:0007215 | 3 / 19 | 86.8× | 5.23e-6 | 3.28e-4 ✓ sig. |
| monoatomic ion transmembrane transport | GO:0034220 | 7 / 404 | 9.5× | 6.81e-6 | 4.03e-4 ✓ sig. |
| potassium ion transmembrane transport | GO:0071805 | 5 / 150 | 18.3× | 7.19e-6 | 4.21e-4 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Chondromyxoid fibroma | Spinocerebellar ataxia, autosomal recessive 13 | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Autosomal recessive spinocerebellar ataxia 18 | Congenital cerebellar ataxia | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Chondromyxoid fibroma | Congenital cerebellar ataxia | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Congenital cerebellar ataxia | Spinocerebellar ataxia, autosomal recessive 13 | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Chondromyxoid fibroma | Temporal lobe epilepsy | 0.029 | 1 | 2.13e-3 | 2.85e-3 ✓ sig. |
| Spinocerebellar ataxia, autosomal recessive 13 | Temporal lobe epilepsy | 0.029 | 1 | 2.13e-3 | 2.85e-3 ✓ sig. |
| Congenital cerebellar ataxia | Temporal lobe epilepsy | 0.029 | 1 | 4.26e-3 | 5.20e-3 ✓ sig. |